본문 바로가기
KERD
논문KCI 등재

남성 근로자의 복부지방두께와 adiponectin, BDNF 및 leptin의 관련성

A Study on the Relationship between Adiponectin, BDNF and Leptin with Abdominal Fat Thickness in Male Workers

0

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류방사선과학

초록

이 연구는 지방조직에서 분비되어 비만의 진행 조절에 관여하는 adiponectin과 leptin의 복부지방두께와의 관련성을 보고자 하였다. 연구대상자는 남성 근로자 138명으로 초음파를 이용하여 피하 및 내장지방두께를 측정하고 ELISA kit을 이용하여 adiponectin, BDNF 및 leptin의 농도를 측정하였다. 그 결과, 대상자의 평균 피하지방과 내장지방두께는 1.58±0.51과 4.52±1.44㎝이었다. Adiponectin, BDNF 및 leptine의 평균농도는 각각 3.14±3.52 ng/㎖, 24.11±8.52 pg/㎖와 4.27±2.38 ng/㎖이었다. 내장지방두께는 총 콜레스테롤, LDL-콜레스테롤, 중성지방 및 인슐린 농도와 양의 상관관계를 보였으나, HDL-콜레스테롤과는 음의 상관관계를 보였다. Adiponectin 농도는 HDL-콜레스테롤의 농도와 양의 상관관계를 보였고 총 콜레스테롤, LDL-콜레스테롤, 중성지방, 피하 및 내장지방두께와는 음의 상관관계를 보였다. 그러나 leptin의 농도는 adiponectin과 상반되는 결과를 보였다. Adiponectin의 농도는 비만하지 않은 대상자(BMI<25 ㎏/㎡)에서 유의하게 높았으나 leptin의 농도는 비만한 대상자((BMI>25 ㎏/㎡)에서 높았다. 비만과 adiponectin, BDNF 및 leptin의 관련성을 보기 위하여, 연령, 흡연 및 음주습관 등을 보정한 다음, 다중 로지스틱 회귀분석을 실시한 결과, 비만은 adiponectin(교차비=0.784, p=0.006)과 leptin(교차비=1.493, p=0.001)이 관련이 있는 것으로 나타났다. 이상의 결과는 adiponectin과 leptin의 농도가 복부지방에 영향을 주고, 이들 신경영양 물질들의 생성과 분비 기능저하는 궁극적으로 비만과 심혈관계 질환의 유발에 관여함을 보여준 결과라 판단된다.

Abstract

Adiponectin (AdipoN), brain-derived nerotrophic factor (BDNF) and leptin (LeP) are mainly secreted from adipose tissue and are known to be involved in regulation of the development of obese. However, there are not many studies on the association between abdominal fat and neuropeptides such as AdipoN, BDNF and LeP. The aim of this study was undertaken to investigate the association between abdominal fat thickness, neuropeptides and cardiovascular disease (CVD) risk factors. The participants in the study were 138 male employees without CVD. This study was approved by the Institutional Review Board of Occupational Safety and Health Research Institute. Written informed consent for the participants in this study was obtained from all individuals. We obtained subcutaneous fat thickness (SFT) and visceral fat thickness (VFT) by using ultrasonography and neuropeptides levels were measured with ELISA kit according to the method suggested by kit manufacturer. The mean SFT and VFT were 1.58±0.51 and 4.52±1.44 cm. The mean concentrations of AdipoN, BDNF and LeP were 3.14±3.52 ng/ml, 24.11+8.52 pg/ml and 4.27±2.38 ng/ml, respectively. VFT were positively correlated with total cholesterol (r=0.217, p<0.05), LDL-cholesterol (r=0.271, p<0.01), triglyceride (r=0.233, p<0.05) and insulin (r=0.338, p<0.01), but was inversely correlated with HDL- cholesterol (r=-420, p<0.01). AdipoN levels were positively correlated with HDL-cholesterol (r=0.220, p<0.05) and were inversely correlated with total cholesterol (r=-0.196, p<0.05), LDL-cholesterol (r=-0.190, p<0.05), triglyceride (r=-0.199, p<0.05), SFT (r=-0.195, p<0.05) and VFT (r=-0.412, p<0.01). However, LeP levels showed a reverse trend to AdipoN. AdipoN level was significantly higher in non-obese participants (BMI<25 kg/m), but LeP concentration was significantly higher in obese participants (BMI>25 kg/m) than in non-obese. On multiple logistic regression analysis, obese were significantly associated with AdipoN (odds ratio=0.784) and LeP (odds ratio=1.494). These results suggested that AdipoN and LeP concentrations are affected abdominal fat and that dysfunction and/or declination in the production and secretion of neuropeptides might induced ultimately obese and CVD.

참고문헌 (40)

  1. Prentice AM, "Beyonf body mass index", Obese Review, 2(3), pp.141~147 (2001)
  2. Redman LM, "Effect of caloric restriction in non-obese humans on physiological, psychological and behavioral outcomes", Physiology and Behavior, 94(5), pp.643~648 (2008)
  3. Prevalence of obesity in the United States, 2009-2010, "Ogden CL", Centre for Disease Control and Prevention (CDC), 1~8, pp.National Center for Health Statistics Data Brief, 82 (2012)
  4. Ogaden CL, "The epidemiology of obesity", Gastroenterology, 132(6), pp.2087~2102 (2007)
  5. Kumanyika S, "Community energy balance: A framework for contextualizing cultural influences on high risk of obesity in ethnic minority populations", Preventive Medicine, 55(5), pp.371~381 (2012)
  6. Pampel FC, "Obesity, SES, and economic development: A test of the reversal hypothesis", Social Science & Medicine, 74(7), pp.1073~1081 (2012)
  7. "보건복지부 질병관리본부 : 국민건강영양조사 제5기 2차년도", ~ (2011)
  8. Kissebah AH, "Relation of body fat distribution to metabolic complication of obesity", J Clin Endocrinol Metab, 54(2), pp.254~260 (1982)
  9. Despres JP, "Abdominal obesity and metabolic syndrome", Nature, 444(7121), pp.881~887 (2006)
  10. Reaven GM, "Banting lecture 1988: Role of insulin resistance in human disease", Diabetes, 37(12), pp.1595~1607 (1988)
  11. Pyorala M, "Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: the 22-year follow- up results of the Helsinki Policemen Study", Arterioscler Thromb Vasc Biol, 20(2), pp.538~544 (2000)
  12. Bjorntorp P, ""Potal" adipose tissue as a generator of risk factors for cardiovascular disease and diabetes", Arteriosclerosis, 10(4), pp.493~496 (1990)
  13. Garg A, "Insulin resistance in the pathogenesis of dyslipidemia", Diabetes Care, 19(4), pp.387~389 (1996)
  14. Boden G, "Fatty acids and insulin resistance", Diabetes Care, 19(4), pp.394~395 (1996)
  15. Storlien LH, "Skeletal muscle membrane lipids and insulin resistance", Lipids, 31, pp.261~265 (1996)
  16. Das UN, "Obesity: Genes, brain, gut, and environment", Nutrition, 26(5), pp.459~473 (2010)
  17. Friedman JM, "Abnomal splicing of the leptin receptor in diabetic mice", Nature, 379(6566), pp.632~635 (1996)
  18. Kadowaki T, "The physiological and pathophysiological role of adiponectin and adiponectin receptors in the peripheral tissues and CNS", FEBS Letters, 582(1), pp.74~80 (2008)
  19. Ahima RS, "Cetral actions of adipocytes hormones", Trands Endocrinol Metab, 16(7), pp.307~313 (2005)
  20. Lam KS, "Adiponectin: protectionof the endothelium", Curr Diab Rep, 5(4), pp.254~259 (2005)
  21. Silha JV, "Plasma resistin, adiponectin and leptin level in lean and obese subjects: correlation with insulin resistance", Eur J Endocrinol, 149(4), pp.331~335 (2003)
  22. Davies AM, "The role of neurotrophins in the developing nervous system", J Neutrobiol, 25(11), pp.1334~1348 (1994)
  23. McAllister AK, "Neurotrophins and neuronal differentiation in the central nervous system", Cell Mol Life Sci, 58(8), pp.1054~1060 (2001)
  24. Lebrun B, "Brain-derived neurotrophic factor(BDNF) and food intake regulation: A minireview", Auto Neuroscience, 126, pp.30~38 (2006)
  25. NCEP-ATPIII, "Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults(Adults Treatment Panel III(2002) final report", Circulation, 106, pp.3143~3421 (2002)
  26. Merino-Ibarra E, "Ultrasonography for the evaluation of visceral fat and the metabolic syndrome", Metab Clin Experimental, 54(9), pp.1230~1235 (2005)
  27. 이현진, "보건소 비만 프로그램을 통한 성인 여성의 체지방율 변화에 따른 건강상태 및 식생활 비교", 석사, 식품영양학, pp.2007
  28. Chen H, "Regulation of hypothalamic NPY by diet and smoking", Peptide, 28, pp.384~389 (2007)
  29. Combs TP, "Endogenous glucose production is inhibited by the adipose-derived protein Acrp30", J Clin Invest, 108(21), pp.1875~1881 (2001)
  30. Duncan BB, "Adiponectin and the development of type 2 diabetes: the atherosclerosis risk in communities study", Diabetes, 53(9), pp.2473~2478 (2004)
  31. Tschritter O, "Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism", Diabetes, 52(2), pp.239~243 (2003)
  32. Maffei M, "Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects", Nat Med, 1(11), pp.1155~1161 (1995)
  33. Considine RV, "Serum immunoreactive -leptin concentrations in normal-weight and obese humans", N Engl J Med, 334(5), pp.292~295 (1996)
  34. Ono M, "Intermittent administration of brain-derived neurotrophic factor ameliorates glucose metabolism in obese diabetic mice", metabolism, 49(1), pp.129~133 (2000)
  35. Ahima RS, "Adipose tissue as an endocrine organ", Trands Endocrinol Metab, 11(8), pp.327~332 (2000)
  36. Minocci A, "Leptin plasma concentrations are dependent on body fat distribution in obese patients", Int J Obese Relat Metab Disord, 24(9), pp.1139~1144 (2000)
  37. Koebnick C, "Leptin-to-adiponectin ratio as independent predictor of insulin sensitivity during growth in overweight Hispanic youth", J Endocrinol Invest, 30(7), pp.RC13~RC16 (2007)
  38. Kwon K, "Reciprocal association between visceral obesity and adiponectin: in healthy premenopausal women", Int J Cardiology, 101(3), pp.385~390 (2005)
  39. Park K-G, "Relationship between serum adiponectin and leptin concentrations and body fat distribution", Diabetes Res Clin Practice, 63(2), pp.135~142 (2004)
  40. Guzik TJ, "Adipocytokines-novel link between inflammation and vascular function?", J Physiol Pharmacol, 57(4), pp.505~528 (2006)

관련 논문AI추천

남성 근로자의 비만이 adiponectin과 leptin의 생리적 농도와 대사증후군 진단지표에 미치는 영향고경선, 김기웅, 원용림, 허경화한국직업건강간호학회 · 한국직업건강간호학회지2009 · 제18권 제1호정상 체중인 성인 남성에서 지방과다와 심혈관질환의 위험요인간의 관련성문용, 권우성, 김준수, 이근미, 정승필, 채진욱영남대학교 의과대학 · Journal of Yeungnam Medical Science2003 · 제20권 제1호비만 여성에서 복부 지방과 인슐린 및 동맥경화성 지표의 관련성김기정, 손혜숙, 이가영, 이남수, 한정희대한가정의학회 · Korean Journal of Family Medicine2002 · 제23권 제7호한국 남성 비알코올성 지방간에서 혈청 adipokine 농도 변화에 영향을 미치는 요인김병익, 김선우, 김홍주, 박동일, 박정호, 손정일, 오기원, 오세용, 오은숙, 유태우, 윤은주, 이원영, 이은정, 전우규, 정찬희, 조용균대한내과학회 · 대한내과학회지2006 · 제71권 제1호비만도에 따른 Adiponectin, Leptin, Ghrelin과 인슐린 저항성, 심혈관 위험인자의 상호 연관성김두만, 김종엽, 김현규, 민선정, 박성우, 박철영, 신현원, 오기원, 유재명, 유형준, 이성진, 임성희, 정인경, 조성휘, 최문기, 홍은경대한내과학회 · 대한내과학회지2005 · 제69권 제6호Relationships between Serum Adiponectin with Metabolic Syndrome and Components of Metabolic Syndrome in Non-Diabetic Koreans: ARIRANG Study고상백, 김장영, 박종구, 유병수, 윤정한, 이승환, 최경훈연세대학교의과대학 · Yonsei Medical Journal2011 · 제52권 제2호

이 간행물의 다른 논문 (5건)